Shilpa Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE790G01031
  • NSEID: SHILPAMED
  • BSEID: 530549
INR
388.00
13.8 (3.69%)
BSENSE

Apr 02

BSE+NSE Vol: 8.66 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shilpa Medicare
Akums Drugs
Viyash Scientifi
Supriya Lifesci.
Marksans Pharma
Sanofi India
Blue Jet Health
P & G Health Ltd
Aarti Pharma
FDC
Sudeep Pharma
Why is Shilpa Medicare Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.57%
  • Poor long term growth as Net Sales has grown by an annual rate of 6.95% and Operating profit at 3.16% over the last 5 years
2
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 2.31% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -22.94% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Shilpa Medicare should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shilpa Medicare for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Shilpa Medicare
19.47%
-0.53
43.30%
Sensex
-4.3%
0.43
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.42%
EBIT Growth (5y)
12.62%
EBIT to Interest (avg)
2.22
Debt to EBITDA (avg)
4.13
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
0.42
Tax Ratio
21.09%
Dividend Payout Ratio
0
Pledged Shares
8.73%
Institutional Holding
19.30%
ROCE (avg)
4.59%
ROE (avg)
2.48%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
41
Industry P/E
31
Price to Book Value
3.11
EV to EBIT
29.88
EV to EBITDA
20.87
EV to Capital Employed
2.71
EV to Sales
5.70
PEG Ratio
0.33
Dividend Yield
0.13%
ROCE (Latest)
8.01%
ROE (Latest)
6.73%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
ROCE(HY)

Highest at 8.57%

OPERATING PROFIT TO INTEREST(Q)

Highest at 10.70 times

NET SALES(Q)

Highest at Rs 409.73 cr

PBDIT(Q)

Highest at Rs 114.30 cr.

PBT LESS OI(Q)

Highest at Rs 72.90 cr.

PAT(Q)

Highest at Rs 54.00 cr.

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Shilpa Medicare
Operating Profit to Interest - Quarterly
Highest at 10.70 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 72.90 cr has Grown at 60.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 45.52 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 409.73 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 409.73 cr has Grown at 22.2% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 335.38 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 114.30 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 72.90 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 54.00 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 54.00 cr has Grown at 31.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 40.98 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)